top of page


Onco-Summaries: Daily Oncology Updates at a Glance
07/07/2025 SIR-Spheres® Y-90 Resin Microspheres received FDA approval for HCC ( Ref ) The US FDA approved Sirtex Medical's SIR-Spheres...
Oncofocus Team
Jul 81 min read


Who Wins the Race for Summit's Ivonescimab?
⭐ Summit Therapeutics, Inc. has reportedly been in partnership discussions with AstraZeneca and other major pharma companies for its...
Oncofocus Team
Jul 72 min read


Onco-Summaries: Daily Oncology Updates at a Glance
04/07/2025 Imfinzi has been approved by the EC as a perioperative immunotherapy for muscle-invasive bladder cancer ( Ref ) AstraZeneca’s...
Oncofocus Team
Jul 71 min read


Onco-Summaries: Daily Oncology Updates at a Glance
02/07/2025 Lynozyfic received accelerated approval from the US FDA for R/R Multiple Myeloma ( Ref ) Regeneron Pharmaceuticals announced...
Oncofocus Team
Jul 32 min read


Onco-Summaries: Daily Oncology Updates at a Glance
01/07/2025 HanchorBio and Henlius signed a ~$200M licensing deal for HanchorBio's HCB101 ( Ref ) HanchorBio and Shanghai Henlius Biotech...
Oncofocus Team
Jul 22 min read


AbbVie is set to acquire University of Pennsylvania’s spinout, Capstan Therapeutics
📢 AbbVie is set to acquire University of Pennsylvania ’s spinout, Capstan Therapeutics for up to $2.1 billion in cash, representing...
Oncofocus Team
Jul 21 min read


Onco-Summaries: Daily Oncology Updates at a Glance
30/06/2025 Revolution Medicines and Summit entered into a clinical collaboration to evaluate RAS(ON) inhibitors and ivonescimab...
Oncofocus Team
Jul 12 min read
bottom of page
.png)